Pfizer (PFE) Current Assets (2009 - 2026)

Pfizer (PFE) has 18 years of Current Assets data on file, last reported at $42.8 billion in Q1 2026.

• Current Assets for Q1 2026 came in at $42.8 billion, down 6.63% year-over-year; the trailing twelve-month figure through Mar 2026 was $42.8 billion (down 6.63% YoY), and the FY2025 annual result was $42.9 billion, down 14.81% from the prior year.
• Current Assets held at $42.8 billion in Q1 2026 per PFE's latest filing, from $42.9 billion in the prior quarter.
• Over five years, Current Assets peaked at $74.0 billion in Q4 2023 and troughed at $5.9 billion in Q4 2022.
• A 5-year average of $48.0 billion and a median of $45.9 billion in 2025 frame the typical range for Current Assets.
• The sharpest annual moves came in 2023 and 2024: Current Assets jumped 1147.67% in 2023, then plunged 48.43% in 2024.
• A 5-year view of Current Assets shows it stood at $51.3 billion in 2022, then fell by 15.46% to $43.3 billion in 2023, then grew by 16.21% to $50.4 billion in 2024, then decreased by 14.81% to $42.9 billion in 2025, then declined by 0.18% to $42.8 billion in 2026.
• Business Quant data shows PFE's Current Assets at $42.8 billion in Q1 2026, $42.9 billion in Q4 2025, and $46.9 billion in Q3 2025.